Related Experiment Video
Updated: May 31, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Pediatric diabetes registries: when baby steps are not enough
1RemedyMD, Sandy, Utah, USA. cmalone@remedymd.com
Journal of Diabetes Science and Technology
|July 5, 2011
Summary
Innovative information technology (IT) solutions, like meta-registries, overcome barriers in diabetes research. These tools improve data collection, analysis, and collaboration, enabling better pattern recognition for multifactorial diseases.
Area of Science:
- Medical Informatics
- Computational Biology
- Diabetes Research
Background:
- Effective diabetes research depends on pattern recognition.
- Current research faces challenges with outdated information technology (IT) and clinical data systems.
- These limitations hinder data collection, analysis, and collaboration.
Purpose of the Study:
- To identify key problems in current diabetes research methodologies.
- To propose innovative IT solutions to overcome these research barriers.
- To enhance pattern recognition and research outcomes in diabetes.
Main Methods:
- Discussion of seven prevalent problems in current diabetes research.
- Introduction of meta-registries and ontologies as IT solutions.
- Explanation of data harmonization and centralization for research.
Main Results:
- Meta-registries with ontologies automatically harmonize data from diverse sources.
- Centralized and harmonized data provide a comprehensive patient view.
- Simultaneous analysis across all data types reveals previously indistinguishable patterns.
Conclusions:
- Innovative IT, specifically meta-registries, can significantly improve diabetes research.
- Overcoming data integration and analysis challenges leads to enhanced pattern discovery.
- These advancements are crucial for multifactorial disease research like diabetes.
Related Concept Videos
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...